Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2012C038 Product name: INTERFERON BETA-1A.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2012C/038
Type:
Certificate
SPC type:
Medical
Basic patent number:
019884667
Status:
Deemed Withdrawn
Publication number:
2012C038
1rst applicant's nationality:
Procedural language:
Dutch

Marketing authorization

Marketing authorization number:
EMEA C20073923
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
14/08/2007
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
14/08/2012
First marketing authorization date:
14/08/2007
Grant date:
Activation date:
26/10/2021
BE Publication date:
04/06/2018
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
14/08/2022
SPC/SPC Extension Expiration (if granted and all annual fees paid):
14/08/2022
Rejection date:
04/06/2021
Withdrawal date:

Applicant

Name:
Novartis Vaccines and Diagnostics, Inc.
Legal Form:
From:
14/08/2012
Address:
4560 Horton Street, Emeryville CA 94608, United States (US)
To:

Agent

1

Name:
GEVERS PATENTS
Legal Form:
From:
08/02/2024
Address:
De Kleetlaan 7A, 1831, DIEGEM, Belgium (BE)
To:

2

Name:
GEVERS PATENTS
Legal Form:
From:
29/06/2021
Address:
Holidaystraat 5, 1831, DIEGEM, Belgium (BE)
To:
08/02/2024

3

Name:
LUYS Marie-José
Legal Form:
From:
14/08/2012
Address:
Holidaystraat 5, 1831, DIEGEM, Belgium (BE)
To:
29/06/2021

Publication

Bulletin

1

Bulletin heading:
SPC
Journal edition number:
2018/14
Publication date:
22/08/2018
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

2

Bulletin heading:
VRV
Journal edition number:
2021/11
Publication date:
15/07/2021
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
31/03/2021 Outgoing Correspondence 3 PDF /8/3/0/2/1/0300012038/docs/2012c038_0_outgoingcorrespondence_20210331_030733911.pdf
04/06/2021 Outgoing Correspondence 1 PDF /8/3/0/2/1/0300012038/docs/2012c038_1_outgoingcorrespondence_20210609_022429469.pdf
04/06/2018 Publication I1 1 PDF /8/3/0/2/1/0300012038/docs/2012c038_2_i1document_20180604_144347472.pdf
19/07/2021 Request For Change Letter and/or Form requesting a change in the Register 3 PDF /8/3/0/2/1/0300012038/docs/2012c038_3_rfc_20210719_050457952.pdf
08/02/2024 Request For Change Letter and/or Form requesting a change in the Register 2 PDF /8/3/0/2/1/0300012038/docs/2012c038_4_rfc_20240425_085642791.pdf